When was Moonwalk founded?

Moonwalk was founded in 2022 and raised its 1st funding round 1 year after it was founded.

Where is Moonwalk located?

Moonwalk is headquartered in San Francisco, United States.

Who is the current CEO of Moonwalk?

Alex Aravanis of Moonwalk. They have also founded 1 company.

How many employees does Moonwalk have?

As of Aug 31, 2026, the latest employee count at Moonwalk is 21.

Is Moonwalk a funded company?

Moonwalk is a funded company, having raised a total of $127M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 18, 2023.

When was the latest funding round of Moonwalk?

Moonwalk's latest funding was a $***** Series B round on Sep 08, 2026, with participation from 7 investors.

Where does Moonwalk rank among its competitors?

Moonwalk ranks 3rd amongst 19 active competitors, of which 9 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Epigenica, which secured $2.2M in Jun, 2025.

Who are the top competitors of Moonwalk?

Moonwalk's top competitors include Biomodal, FOXO Technologies and Epigenica. Among them, Moonwalk secured the most recent funding round in September, 2026.

Moonwalk - 2026 Company Profile, Team, Funding & Competitors

Company Details

Digital platform pioneering precision epigenetic medicines. The company has developed a differentiated approach to mapping the epigenome of cellular states at the whole genome, single cell resolution level, as well as proprietary strategies for precise epigenetic engineering.

Key Metrics

Founded Year

2022

Location

San Francisco, United States

Stage

Series B

Total Funding

$127M in 3 rounds

Latest Funding Round

Series B, Sep 08, 2026, $*****

Investors

Khosla Ventures & 4 more

Ranked

3^rd among 19 active competitors

Employee Count

21 as on Aug 31, 2026

Similar Companies

Biomodal & 19 more

View Moonwalk's full profile

Moonwalk has raised a total funding of $127M over 3 rounds. Its first funding round was on Dec 18, 2023. Its latest funding round was a Series B round on Sep 08, 2026 for $*****. 7 investors participated in its latest round. Moonwalk has 5 institutional investors.

Here is the list of recent funding rounds of Moonwalk:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 08, 2026	8280231	Series B	2598655	5182283	6988651	7818887
Jan 04, 2024	7083339	Series A	2560360	3610648	9278381	2319859
Dec 18, 2023	8406451	Seed	1242820	7342234	Arch Venture Partners & 4 more	4663739

Access funding benchmarks and valuations. Sign up today!

View details of Moonwalk's funding rounds and investors

The founders of Moonwalk are Feng Z, Alex Aravanis and Justin Valley. Alex Aravanis is the CEO of Moonwalk.

Here are the details of Moonwalk's key team members:

Feng Z: Co-Founder of Moonwalk.
Alex Aravanis: Co-Founder & CEO of Moonwalk.
Contact Info: 1 email address
Justin Valley: Co-Founder of Moonwalk.
Contact Info: 1 email address

View details of Moonwalk's Founder profiles and Board Members

Moonwalk's employee count trend

Moonwalk has 21 employees as of Aug 26. Here is Moonwalk's employee count trend over the years:

Uncover Moonwalk's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Moonwalk include Biomodal, FOXO Technologies and Epigenica. Here is the list of Top 10 competitors of Moonwalk, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Biomodal 2012, Cambridge (United Kingdom), Series D	Developer of a duet multiomics platform that generates genetic and epigenetic data	$164M	Temasek, Google Ventures & 23 others	63/100
2nd	FOXO Technologies 2020, Minneapolis (United States), Public	Provider of epigenetic diagnostic services alongside rural and behavioral hospitals	$40M	Bespoke Growth Partners, Inc., Centrecourt Asset Management ... Read more	60/100
3rd	Moonwalk 2022, San Francisco (United States), Series B	Digital platform pioneering precision epigenetic medicines	$127M	Google Ventures, Alpha Wave Global & 3 others	61/100
4th	Epigenica 2020, Stockholm (Sweden), Seed	Provider of solutions for the analysis of genomic data	$2.2M	Voima Ventures, Europa & 4 others	45/100
5th	Chroma Medicine 2020, Cambridge (United States), Series B	Developer of an epigenetic editing platform for genomic medicines	$260M	Atlas Venture, Google Ventures & 16 others	45/100
6th	Chronomics 2017, Norwich (United Kingdom), Seed	Provider of an online digital platform for epigenetics data	$1.43M	SOSV, Anthemis Group & 3 others	42/100
7th	Reaction Biology 2001, United States, Late Stage	In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling	-	Cobepa, CYwP Funds & 6 others	40/100
8th	Yijie Like Shanghai (China), Seed	Developer of epigenetic regulation technology to treat a variety of diseases	$14.8M	Morningside, Xicheng Jinrui & 3 others	37/100
9th	Peconic 2012, State College (United States), Unfunded	Provider of precision mapping for epigenomic research	-	-	30/100
10th	Histone Therapeutics 2021, Seattle (United States), Funding Raised	Developer of epigenetic reprogramming therapies for gene activation	-	National Science Foundation	30/100